Cambridge, MA – Governor Charlie Baker, the Massachusetts Life Sciences Center, and MassBio recently commended Eli Lilly for their decision to expand into Massachusetts by opening a new 17,000sf facility in Kendall Square, Cambridge. The facility, focused on the development of improved drug delivery systems and devices, will house approximately 30 new employees.
“We welcome Eli Lilly’s expansion here in the commonwealth, and look forward to their ongoing contributions to our thriving life sciences community,” said Governor Charlie Baker.
Eli Lilly and Company is a leading global pharmaceutical company with headquarters located in Indianapolis, Indiana and facilities in 17 countries. The company has approximately 41,000 employees worldwide, with more than 8,000 engaged in research and development.
“Eli Lilly is joining a growing list of global leaders that recognize the value of our state’s investment in strengthening the Massachusetts life sciences innovation ecosystem,” said Susan Windham Bannister, Ph.D., president and CEO of the MLSC. “We are extremely excited that Eli Lilly is joining our life sciences community and look forward to supporting the company’s growth and success.”
“We are thrilled to welcome Eli Lilly to Massachusetts and look forward to their active participation in our thriving healthcare ecosystem,” said Robert K. Coughlin, president and CEO of MassBio, a 650+ member life sciences trade association. “The company’s focus on innovation in delivery and its long-time commitment to collaboration will be welcomed with open arms by our local, growing companies, institutions, and organizations.”
